What’s new in Diagnostics: Novel HIV Molecular Interventions to Support Expansion of Viral Load Access
Co-Chairs: Nqobile Ndlovu (ASLM) and Meg Doherty (WHO)
Currently, approximately 50% of patients on antiretroviral treatment have access to viral load testing; however, access remains focused within a small number of countries. While plasma is the preferred specimen type for viral load testing, it can be restrictive in settings with limited infrastructure and cold chain availability. Additionally, several challenges and barriers remain to widely scaling up viral load. In this Satellite, ASLM, WHO and partners will present new and tried concepts for scaling up HIV viral load testing across settings – these concepts form a newly developed implementation best practices document to be launched during this session.
Venue: Casa del Diezmo 3 y 4 (SR6), Centro Citibanamex, Mexico City
Date: Monday 22 July
Time: 6:30 pm - 8:30 pm